JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, cilt.139, sa.8, ss.1373-1382, 2013 (SCI-Expanded)
Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) participate in tumorigenesis, and their association with disease outcome is highly controversial. The present study investigates the influence of MMP-1, MMP-9 and TIMP-2 on different clinicopathologic variables and disease-free survival (DFS) of patients with prostate carcinoma.